New
Precision Biotechnology for the Human Heart.
From Stem Cell to Clinical Innovation, Virelion is Transforming the Future of Cardiac Care
Our Services
Cardiotechnology That Restores, Enhances, and Interfaces with the Human Heart
We design, develop, and deploy advanced cardiac technologies that restore function and redefine the limits of heart performance.
Virelion BioEP™
Human Cardiac Electrophysiology Research Platform
Advancing translational cardiac electrophysiology through human iPSC-derived cardiomyocyte models, computational analysis, and bioelectrical research focused on arrhythmia mechanisms and next-generation cardiac therapies.
iPSC
Arrhythmia Modeling
Translational Research
Virelion ElectroReg™
Cardiac Conduction System Regeneration Research
Focused on restoring damaged cardiac conduction pathways through engineered cellular replacement strategies and bioelectrical integration of regenerated cardiomyocytes.
Conduction system repair
Bioelectrical integration
Tissue-level regeneration
Virelion RhythmRestore™
Functional Restoration of Cardiac Electrical Activity
Development of regenerative strategies aimed at re-establishing stable cardiac rhythm through repair of diseased or fibrotic electrical microenvironments.
Rhythm restoration
Electrical microenvironment repair
Anti-arrhythmic regeneration
Virelion CardioRepair™
Translational Regenerative Cardiac Electrophysiology
A translational framework connecting iPSC-derived regenerative biology with therapeutic strategies for repairing electrophysiological dysfunction in diseased myocardium.
Translational regeneration
Electrophysiology repair
Myocardial functional recovery
Case Studies